Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.

Name: Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
Author: Evans, I

Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity. — المؤلف: Evans, I — Experimental cell research Aug 1977

المؤلف: Evans, I
النشر: Experimental cell research Aug 1977
الوصف: 151-5 p.
الموضوعات: Bromodeoxyuridine؛ Cell Division؛ Cell Line؛ Dose-Response Relationship, Drug؛ Hydrogen-Ion Concentration؛ Peptide Hydrolases؛ Thymidine